About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, February 18th, 2016

The QualityStocks
Daily Stock List


Tasman Metals Ltd. (TASIF)

InvestorIntel reported this month on Tasman Metals Ltd. (TASIF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Tasman Metals Ltd.’s concentration is on critical metals and minerals including Rare Earth Elements (REE's), nepheline, feldspar and tungsten (W) in Scandinavia. Its portfolio includes the flagship Norra Karr heavy REE project. This project has the capacity to deliver all of Europe's needs for the high value metals dysprosium (Dy), terbium (Tb), yttrium and neodymium for 20 years.

Tasman Metals is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB. It established in October of 2009, from the amalgamation of private Canadian company Tasman Metals Ltd. and two capital pool companies Ausex Capital Corp. and Lumex Capital Corp.

The above-mentioned materials and metals are high value. They provide the function to many new alloys and coatings. Demand is rising because of their application in emerging technologies. These include green energy production and storage, communication and electric mobility.

More than 90 percent of REE and tungsten supply comes from The People’s Republic of China (PRC). The European Commission is active to ensure secure domestic supply of critical metals. Tasman Metals’ exploration portfolio is uniquely placed and can deliver these critical metals and materials from politically stable, mining friendly jurisdictions with developed infrastructure and skills.

The Company has extensive claim holdings in Sweden, Finland and Norway. These particular holdings are prospective for strategic metals. These include rare earth elements (REE's) and iron ore. The Scandinavian countries provide beneficial infrastructure, an intelligent workforce, modern mining legislation with low or no royalties, and also large regions of relatively unexplored ground. The Scandinavian region provides a stable political and economic environment with a developed mining culture.

Tasman Metals is managed by resource professionals who are implementing major cost control measures across the Company’s business to preserve its asset position during this cyclical industry low. Tasman said that it has started a review of potential strategic alternatives, which could assist in creating maximum shareholder value during what the Company states as “these challenging market conditions.”

Tasman Metals Ltd. (TASIF), closed Thursday's trading session at $0.1051, up 1.15%, on 22,300 volume with 6 trades. The average volume for the last 60 days is 6,538 and the stock's 52-week low/high is $0.088/$0.738.

Earth Science Tech, Inc. (ETST)

Penny Stocks Profile, Juicy Penny Stocks, OtcShortReport, Cannabis Financial Network News, Value Penny Stocks, StockMarketIntel, Hot Stock Profits, OTCStars.com, SmallCapVoice, GoldminePennyStocks and Equity Observer reported earlier on Earth Science Tech, Inc. (ETST), and we choose to highlight the Company also, here at the QualityStocks Daily Newsletter.

Earth Science Tech, Inc. is a biotechnology company focusing on pioneering nutraceuticals, bioceuticals, and dietary supplements for the health, nutrition, sports, wellness, and alternative medicine markets. The Company also provides natural alternatives to prescription medications through nutritional supplements and dietary supplements. This may include CBD (Cannabidiol) as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products. Earth Science Tech is based in Boca Raton, Florida.

The Company’s goal is to be the leading supplier of the highest quality hemp oil enriched with high grade CBD. Its primary aim is to advance different high quality hemp extracts with an extensive profile of Cannabinoids and additional natural molecules found in industrial hemp and to identify their individual properties. Cannabinoids (Cannabidiol/CBD) are natural constituents of the hemp plant. CBD is derived from hemp stalk and seed.

Earth Science Tech’s high grade CBD rich hemp oil has no fillers, preservatives or additives. It is scientifically formulated, 100 percent natural, and derived from the industrial hemp plant with less than .03 percent THC. It is legal and available to ship to all 50 states and over 40 countries.  

In 2015, Earth Science Tech announced its formation of a new wholly-owned subsidiary Earth Science Tech Bioceuticals, Inc. and at the same time elected Mr. Joseph Pavlik as President.  Earth Science Tech Bioceuticals will be developing, bringing to market, and also merchandising many innovative products and brands featuring the Earth Science Tech High Grade Hemp CBD Oil. Some of these new products include a novel micronized spray series and an advanced active lifestyle nutrition series featuring ultra-premium hemp based formulations.

For 2016, the Company’s objective is to lead the way in the research on High Grade Hemp CBD (Cannabidiol) Oil and Products. Its belief is that further studies will continue to confirm the many potential health and wellness benefits of Hemp CBD and Phytocannabinoids. Earth Science Tech’s intention is to expand its research efforts on its High Grade Hemp CBD (Cannabidiol) Oil and Products through diverse means.

Earlier this month, Earth Science Tech announced that its Board of Directors approved the launch of a Company Sponsored Phytocannabinoid-CBD Research Foundation. The chief emphasis and purpose of this New Non- Profit 501(c) corporation, Earth Science Tech Foundation, is to further studies regarding Phytocannabinoid-CBD (Cannabidiol) Rich Hemp Oil and its potential medicinal benefits.

Earth Science Tech, Inc. (ETST), closed Thursday's trading session at $0.25, even for the day, on 15,490 volume with 5 trades. The average volume for the last 60 days is 6,002 and the stock's 52-week low/high is $0.18/$2.50.

Searchlight Minerals Corp. (SRCH)

SmarTrend Newsletters reported earlier on Searchlight Minerals Corp. (SRCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Searchlight Minerals Corp. involves in the acquisition and exploration of mineral properties and slag reprocessing projects. An exploration stage enterprise, the Company is centering on the acquisition and development of projects in the southwestern U.S. The Company holds interests in the Clarkdale Slag Project. The Project is situated in Clarkdale, Arizona.  Searchlight Minerals is headquartered in Henderson, Nevada and the Company’s shares trade on the OTC Markets Group’s OTCQB.

The Clarkdale Slag Project is a reclamation project to recover precious and base metals from the reprocessing of slag produced from the smelting of copper ore mined at the United Verde Copper Mine in Jerome, Arizona.  Searchlight Minerals announced in May 2014 significant technical achievements in gold and iron recovery at its Clarkdale Slag Project.

The achievements include, but are not limited to, the determination of the exact nature of the gold contained in the slag material; the addition of a high temperature pre-treatment step that aids in the recovery of the gold and provides a saleable iron by-product; and up to a 60 percent extraction of metallic gold from fire assay of ion exchange resin. Searchlight Minerals’ belief is that the project is commercially viable, if repeatable, at present results, based on these achievements.

The Company announced in August of 2015 that it raised $3.27 million across three rounds of financings for working capital purposes. In addition, it received results of certain bench scale tests conducted by Midrex Technologies, Inc., a wholly-owned subsidiary of Kobe Steel, Ltd., to examine the effectiveness of its technology as a potentially more cost effective pre-treatment way to extract iron from its slag material in Clarkdale, Arizona.

Regarding its current work program, Searchlight Minerals is now working on Thermal Pre-treatment Testing; Autoclave Optimization; and Third Party Review and Verification to move expeditiously towards commercial operation. The Company has hired an independent team of well qualified and experienced experts to complete a technical review of the Clarkdale Slag Project. The anticipation is that a favorable report from this review would be used to facilitate the financing of the bankable feasibility study and commercial production facility.

Searchlight Minerals Corp. (SRCH), closed Thursday's trading session at $0.085, up 6.25%, on 50,000 volume with 8 trades. The average volume for the last 60 days is 68,521 and the stock's 52-week low/high is $0.06/$0.44.

Chuma Holdings, Inc. (CHUM)

Cannabis Financial Network News, Investors Alley, Trade of the Week, StreetAuthority Financial, Investopedia, and TopPennyStockMovers reported on Chuma Holdings, Inc. (CHUM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Chuma Holdings, Inc. and its wholly-owned subsidiaries provide turnkey financing and support solutions to the fast developing and increasing legal cannabis industry. The Company’s experienced management team has a combined 35 years of successful experience in the legal cannabis industry in the State of California. Chuma provides "seed to sale" key business services. Chuma Holdings is headquartered in Beverly Hills, California.

The Company provides turnkey financing, services, and Chuma Certification for organizations in the legal cannabis industry. Its "seed to sale" key business services include funding & financing solutions, compliance consulting, and retail, collective and dispensary solutions. In addition, its services include commercial build out and equipment solutions, supply chain solutions, branding, marketing and sales solutions, and banking and payment processing solutions.

Additionally, Chuma’s services include research & development (R&D) solutions and consumer product solutions. Presently, the Company is producing revenue from existing financing and service solutions. It is planning on expanding throughout California. Moreover, it is planning on bringing its collection of services to each new state that legalizes the use of cannabis.

Essentially, Chuma Holdings’ mission is to be the premier financing and turnkey support services company specializing in the legal cannabis industry in the U.S. Its aim is to build an array of turnkey solutions to open model dispensaries, production facilities, and product companies operating as community stewards for good business practice.

Chuma Holdings announced in 2014 that it acquired Paul Shively & Associates, Inc. (PSA). PSA is an industry leader in corporate compliance in the legal cannabis industry. In the California medical marijuana field, PSA brings seven years of expertise in the design, operation, compliance and required day-to-day mandates needed to run a legal collective, production and product company in California. Acquiring PSA provides Chuma Holdings the intellectual property (IP) Mr. Shively and his team have created over the prior seven years.

Chuma Holdings has entered into a Services Agreement with Vertical Meds, a service of KB Delivery, Inc., a California Mutual Benefit corporation, not for profit, medical marijuana delivery service. Vertical Meds is a leader in meeting the requirements of its patient base. It is ready to become one of the first "state issued" licenses under the recently signed AB 266 legislation in the State of California. Vertical Meds is particular about the products it provides through private label packaging and the vertical integration of products it has developed.

Concerning Chuma Holdings’ Commercial Build Out and Equipment Solutions, the Company’s skilled team provides modular turnkey build-out and commercial service options to its clients. Chuma customizes its solutions to address the needed design, build, and roll-out services for infrastructure, systems and the continuing support of retail dispensaries, collectives, as well as production facilities.

Chuma Holdings, Inc. (CHUM), closed Thursday's trading session at $0.0424, up 21.14%, on 5,150 volume with 3 trades. The average volume for the last 60 days is 61,871 and the stock's 52-week low/high is $0.035/$0.49.

BG Medicine, Inc. (BGMD)

PennyStocks24, PennyStockProphet, Penny Pick Finders, SecretStockPromo, StockOnion, Buzz Stocks, Planet Penny Stocks, Top Stock Picks, and Investing Futures reported earlier on BG Medicine, Inc. (BGMD), and we report on the Company today, here at the QualityStocks Daily Newsletter.

BG Medicine, Inc. is the developer of the BGM Galectin-3® Test. BGM Galectin-3® (Galectin-3 Assay) is an in vitro diagnostic device. The Company concentrates on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. Basically, its commitment is to developing and delivering ground-breaking solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. BG Medicine is headquartered in Waltham, Massachusetts.

BGM Galectin-3® (Galectin-3 Assay) quantitatively measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay (ELISA) on a microtiter plate platform. BGM Galectin-3 is indicated to be used in combination with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with heart failure. Additionally, BGM Galectin-3 is indicated to identify adults with an elevated level of galectin-3, which is associated with a greater risk for new-onset heart failure.

Galectin-3 is a structurally unique member of a family of beta-galactoside-binding lectins. Expression of galectin-3 has been associated with the epithelium and inflammatory cells. These include macrophages, neutrophils, and mast cells. Galectin-3 has been implicated in a variety of biological processes vital in heart failure. This includes myofibroblast proliferation, fibrogenesis, tissue repair, cardiac remodeling, and also inflammation.

BG Medicine has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere, Inc. for the automated instrument versions of galectin-3 test. BG also has a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators.

Countries into which the product can be commercially distributed (CE Mark), include Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Germany, Hungary, Iceland, Ireland, and Italy. The product can also be commercially distributed to Liechtenstein, Luxembourg, Malta, Netherlands, Poland, Romania, Spain, Sweden,
Switzerland, Slovakia, Slovenia, and the United Kingdom.

This past December, BG Medicine announced that it submitted to the US Food and Drug Administration (FDA) a notice of withdrawal of its 510(k) premarket notification filing with the FDA submitted to obtain regulatory clearance to market its BGM Galectin-3® Test for a potential new indication for use as an aid in the assessment of the near-term risk of fatal cardiovascular events in older adults who have no previous history of cardiovascular disease, cerebrovascular disease or vascular disease.

Mr. Paul R. Sohmer, M.D., President and CEO of BG Medicine, said, “We believe that the decision to withdraw this submission and to evaluate the possibility of pursuing the assessment of near-term risk for both fatal and non-fatal cardiovascular events among older adults, a more clinically useful indication for use, provides the best opportunity to create value from the work that we have completed to date. That being said, our primary focus near term remains the U.S. market introduction of automated testing for galectin-3.”

BG Medicine, Inc. (BGMD), closed Thursday's trading session at $0.40, up 12.83%, on 34,774 volume with 36 trades. The average volume for the last 60 days is 66,887 and the stock's 52-week low/high is $0.235/$4.20.


The QualityStocks
Company Corner


Nutra Pharma Corp. (NPHC)

The QualityStocks Daily Newsletter would like to spotlight Nutra Pharma Corp. (NPHC). Today, On the Move Systems, Inc. closed trading at $0.0372, off by 17.15%, on 675,418 volume with 17 trades. The stock’s average daily volume over the past 60 days is 449,667, and its 52-week low/high is $0.0025/$0.27.

Nutra Pharma Corp. today announced that the company will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at The Ritz-Carlton in Miami on South Beach on February 22, 2016. Please click here for a list of presenting companies. Each company will be provided with a 30-minute time slot to present to an audience of investors and industry professionals and company management will also be available for one-on-one meetings with institutional investors.

Nutra Pharma Corp. (NPHC) is a biotech company working in collaboration with its subsidiaries to develop an innovative pipeline of biopharmaceutical products for the management of neurological disorders, cancer, autoimmune, and infectious diseases. At the core of Nutra Pharma's intellectual property is a unique platform for extracting neurotoxins from Asian cobra venom and transforming them into non-toxic therapeutics.

The ReceptoPharm subsidiary, Nutra Pharm's drug discovery arm, is focused on the development of new therapeutic agents based upon specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra. ReceptoPharm's R&D pipeline consists of several novel therapies in various stages of development to prevent and/or treat multiple sclerosis (MS), human immunodeficiency virus (HIV), adrenomyeloneuropathy (AMN), herpes, rheumatoid arthritis (RA) and pain. The subsidiary also provides small and start-up biotech companies a full range of contract research services through its ISO class 5 and GMP certified facilities in Plantation, Florida.

Nutra Pharma recently received Orphan Drug Status from the FDA for the treatment of pediatric MS for its drug, RPI-78M. The designation of RPI-78M as an Orphan Drug provides Nutra Pharma with a seven-year period of market exclusivity in the U.S. once the drug is approved. Additional benefits over conventional drug applications include: tax credits for clinical research costs, the ability to apply for grant funding, clinical trial design assistance, plus assistance from the FDA in the drug development process and the waiver of Prescription Drug User Fee Act (PDUFA) filing fees which could be in excess of $2.5 million. The granting of Orphan Drug Designation allows Nutra Pharma to move forward with its preparation of an Investigative New Drug Application and proposal of clinical trials. The FDA grants Orphan Drug Designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics.

ReceptoPharm holds all of the intellectual property for Nutra Pharma's drug pipeline, while Nutra Pharma directly holds all of the property dealing with their over-the-counter drugs. This includes Nyloxin, an OTC pain reliever for humans, and Pet Pain-Away, a pain reliever for dogs and cats. The company's Nyloxin product is the first OTC pain reliever clinically proven to treat moderate to severe chronic pain. The drug is available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Nutra Pharma is a revenue-generating company with 12 patents and patents pending, three completed phase 1/phase 2 clinical trials, and 12 FDA-registered OTC products in the United States. The company also has regulatory clearance for Nyloxin in India, where management believes its initial distribution streams could become the company's biggest market. Management is also defining its plan to expand into China and Canada while strengthening its position the United States. Disclaimer

Nutra Pharma Corp. Company Blog

Nutra Pharma Corp. News:

Nutra Pharma to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

Nutra Pharma Announces Management Expansion and Business Updates

Nutra Pharma Corp.’s (NPHC) 7-year Marketing Exclusivity for Pediatric MS RPI-78M is more than just Luck

View Systems, Inc. (VSYM)

The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.00189, up 18.13%, on 109,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 631,135, and its 52-week low/high is $0.0011/$0.0151.

View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.

The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.

The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.

Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer

View Systems, Inc. Company Blog

View Systems, Inc. News:

View Systems, Inc. (VSYM) to Acquire Y.M. Advantage, Inc.

View Systems in Discussions With Three M&A Candidates and Reviewing Letter of Intent

View Systems, Inc. Files for Patent, Begins Manufacturing of Enhanced ViewScan Product

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.0132, up 1.54%, on 108,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 69,535, and its 52-week low/high is $0.0055/$0.045.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Alternet Systems (ALYI) CEO Featured in Exclusive QualityStocks Interview

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $4.077, off by 4.16%, on 2,310 volume with 6 trades. The stock’s average daily volume over the past 60 days is 819, and its 52-week low/high is $4.254/$6.50.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research

Moxian, Inc. Establishes Beijing Subsidiary, Defines Expansion Plans

FlexWeek (FXWK)

The QualityStocks Daily Newsletter would like to spotlight FlexWeek (FXWK). Today, FlexWeek closed trading at $1.10, even for the day. The stock’s average daily volume over the past 60 days is 200, and its 52-week low/high is $0.075/$1.15.

FlexWeek (FXWK) is a pioneer in the global peer-to-peer (P2P) marketplace with the introduction of a unique platform that allows timeshare owners to discover, book and offer unused vacation time directly to the public and other timeshare owners. This approach eliminates the need for timeshare owners to use costly trading platforms such as Interval International or RCI, while potentially reducing unused timeshare inventory.

FlexWeek's P2P website (www.FlexWeek.com) and mobile application is similar to AirBNB's $20 billion approach to the travel industry, but is the first and only P2P marketplace exclusive to fractional vacation ownerships. FlexWeek differs from the existing model, where timeshare weeks must be "banked" with a trading company such as Interval International or RCI, and instead charges the booking fees to the renter of the vacation time, eliminating the cost to the private timeshare owner.

The FlexWeek platform also addresses another specific industry challenge. The average timeshare is only booked 79% of the year, according to the American Resort Development Association's 2012 research survey. Whether or not a privately owned timeshare unit is used, the owner still has to pay annual maintenance fees, and most owners end up losing thousands of dollars in wasted paid-for vacation time over their ownership period. With FlexWeek, an owner of unused paid vacation time can now offer their specific booked week for rent directly to the FlexWeek marketplace to recoup cost or even make a profit on the rental. The glut of unused timeshare inventory allows a potential renter to stay in a very nice condo for a fraction of what they would pay in hotel fees making it a win-win for both the owner and the renter of the vacation time.

Led by founder Kristopher Chavez, who has more than 10 years of experience operating businesses that acquire, rent, sell and transfer timeshares internationally, FlexWeek's management team will leverage its collective expertise to facilitate the company's direction and growth in this new market. FlexWeek's leadership has founded rapidly growing sales organizations generating 8-figure revenues within a year's time, and has experience scaling other models to financial success and/or acquisition rapidly with limited investment. Disclaimer

FlexWeek Company Blog

FlexWeek News:

FlexWeek, Inc. (FXWK) Announces Engagement of QualityStocks Corporate Communications Suite

FlexWeek, Inc. (FXWK) is “One to Watch”

FLEXWEEK INC Financials EDGAR Online (Sat, Dec 19)


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251